Cerbios-Pharma SA is a Swiss contract development and manufacturing organization (CDMO) focused on active pharmaceutical ingredients (APIs), with a recognized specialization in high-potency APIs (HPAPIs) used notably in oncology and other critical therapeutic areas. The company supports pharmaceutical and biotech clients from early process development through clinical and commercial cGMP manufacturing.
Capabilities span route scouting, process optimization, scale-up, technology transfer, and validated commercial production under stringent containment for potent compounds. Cerbios operates under international quality and regulatory standards, supplying global markets with APIs and intermediates and offering integrated project management across the product lifecycle.
Manufacturing is concentrated on a single site in Switzerland, providing multiple contained production units and flexibility for different batch sizes. Cerbios serves as a partner for companies requiring reliable HPAPI development and supply, combining chemical process expertise with robust safety and quality systems.